Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720719/
https://www.ncbi.nlm.nih.gov/pubmed/29216294
http://dx.doi.org/10.1371/journal.pone.0189549
_version_ 1783284712792391680
collection PubMed
description
format Online
Article
Text
id pubmed-5720719
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57207192017-12-15 Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma PLoS One Correction Public Library of Science 2017-12-07 /pmc/articles/PMC5720719/ /pubmed/29216294 http://dx.doi.org/10.1371/journal.pone.0189549 Text en © 2017 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
title Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
title_full Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
title_fullStr Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
title_full_unstemmed Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
title_short Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
title_sort correction: clinical validation of a highly sensitive assay to detect egfr mutations in plasma cell-free dna from patients with advanced lung adenocarcinoma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720719/
https://www.ncbi.nlm.nih.gov/pubmed/29216294
http://dx.doi.org/10.1371/journal.pone.0189549
work_keys_str_mv AT correctionclinicalvalidationofahighlysensitiveassaytodetectegfrmutationsinplasmacellfreednafrompatientswithadvancedlungadenocarcinoma

Ejemplares similares